Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00686647 · ClinicalTrials.gov registry record · NA

AngioSculpt® Coronary Bifurcation Study

A NA study of Coronary Artery Disease and Myocardial Ischemia, sponsored by AngioScore.

Completed
Registry status
NA
Development phase
93
Enrollment target
1
Study location

NCT00686647 is a NA study of Coronary Artery Disease and Myocardial Ischemia that has completed, run by AngioScore. The registered enrollment target is 93 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00686647, a NA study of Coronary Artery Disease and Myocardial Ischemia, has completed, sponsored by AngioScore.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.

Interventions

  • DEVICE AngioSculpt® Scoring Balloon Catheter
  • DEVICE AngioSculpt Scoring Balloon Catheter

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2008-04
Est. Completion 2011-01
Phase NA

Sponsor

AngioScore

1 total trials

What the Registry Record Tells You About NCT00686647

The ClinicalTrials.gov registry entry for NCT00686647 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The listed sponsor is AngioScore, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which AngioSculpt® Scoring Balloon Catheter is the first listed.

NCT00686647 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00686647 about?

NCT00686647 is a clinical study titled "AngioSculpt® Coronary Bifurcation Study". The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.

What is the current status of trial NCT00686647?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2008-04. Estimated completion is 2011-01.

What conditions does trial NCT00686647 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Ischemia.

What interventions are being tested in trial NCT00686647?

The interventions under investigation include: AngioSculpt® Scoring Balloon Catheter (DEVICE), AngioSculpt Scoring Balloon Catheter (DEVICE).

Who is sponsoring clinical trial NCT00686647?

This trial is sponsored by AngioScore, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00686647 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.